PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to test the effectiveness and safety of a new peptide-based coagulant, PeproStat. The study drug will be applied to patients undergoing liver/soft tissue surgery, vascular surgery or spine surgery. The speed of action of the new coagulant, that is applied with a gelatin sponge, will be compared to the same sponge but with saline (a commonly used standard of care).
Epistemonikos ID: 40903d5f873dce1ec8c40908ba8a8f260a414b52
First added on: May 20, 2024